Literature DB >> 10574987

Distinct factor requirements for exonic splicing enhancer function and binding of U2AF to the polypyrimidine tract.

Y Li1, B J Blencowe.   

Abstract

Exonic splicing enhancer (ESE) sequences are important for the recognition of adjacent splice sites in pre-mRNA and for the regulation of splice site selection. It has been proposed that ESEs function by associating with one or more serine/arginine-repeat (SR) proteins which stabilize the binding of the U2 small nuclear ribonucleoprotein particle (snRNP) auxiliary factor (U2AF) to the polypyrimidine tract upstream of the 3' splice site. We have tested this model by analyzing the composition of splicing complexes assembled on an ESE-dependent pre-mRNA derived from the doublesex gene of Drosophila. Several SR proteins and hTra2beta, a human homolog of the Drosophila alternative splicing regulator Transformer-2, associate with this pre-mRNA in the presence, but not in the absence, of a purine-rich ESE. By contrast, the 65-kDa subunit of U2AF (U2AF-65 kDa) bound equally to the pre-mRNA in the presence and absence of the ESE. Time course experiments revealed differences in the levels and kinetics of association of individual SR proteins with the ESE-containing pre-mRNA, whereas U2AF-65 kDa bound prior to most SR proteins and hTra2beta and its level of binding did not change significantly during the course of the splicing reaction. Binding of U2AF-65 kDa to the ESE-dependent pre-mRNA was, however, dependent on U1 snRNP. The results indicate that an ESE promotes spliceosome formation through interactions that are distinct from those required for the binding of U2AF-65 kDa to the polypyrimidine tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574987     DOI: 10.1074/jbc.274.49.35074

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

2.  Genomic mRNA profiling reveals compensatory mechanisms for the requirement of the essential splicing factor U2AF.

Authors:  Vinod Sridharan; Joseph Heimiller; Ravinder Singh
Journal:  Mol Cell Biol       Date:  2010-12-13       Impact factor: 4.272

3.  Characterization of a U2AF-independent commitment complex (E') in the mammalian spliceosome assembly pathway.

Authors:  Oliver A Kent; Dustin B Ritchie; Andrew M Macmillan
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  Characterization of U2AF(6), a splicing factor related to U2AF(35).

Authors:  Jeremiah Shepard; Martin Reick; Sara Olson; Brenton R Graveley
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

5.  The role of U2AF35 and U2AF65 in enhancer-dependent splicing.

Authors:  B R Graveley; K J Hertel; T Maniatis
Journal:  RNA       Date:  2001-06       Impact factor: 4.942

6.  Dual function for U2AF(35) in AG-dependent pre-mRNA splicing.

Authors:  S Guth; T Ø Tange; E Kellenberger; J Valcárcel
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

7.  Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex.

Authors:  Shalini Sharma; Arnold M Falick; Douglas L Black
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

8.  Direct repression of splicing by transformer-2.

Authors:  Dawn S Chandler; Junlin Qi; William Mattox
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Establishment of a novel in vivo sex-specific splicing assay system to identify a trans-acting factor that negatively regulates splicing of Bombyx mori dsx female exons.

Authors:  Masataka G Suzuki; Shigeo Imanishi; Naoshi Dohmae; Tomoe Nishimura; Toru Shimada; Shogo Matsumoto
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

10.  A conditional role of U2AF in splicing of introns with unconventional polypyrimidine tracts.

Authors:  Vinod Sridharan; Ravinder Singh
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.